| 2M7C Stock | | | EUR 0.91 0.00 0.00% |
Executive
Dr. Wong Wai Ming serves as Chief Technical Officer of China Medical System Holdings Limited since 2010. He first joined the Group in 2000 and then became the Chief RD Officer in 2007. He is responsible for dealing with technical issues in introducing products and providing technical advice to the Group for selecting pharmaceutical products. Prior to this, Dr. Wong worked as manager of China pharma department for Jebsen Co. Ltd. He studied biochemistry and received his bachelors degree in science and PhD from the University of Hong Kong in 1983 and 1993, respectively. since 2010.
| Age | 62 |
| Tenure | 15 years |
| Professional Marks | Ph.D |
| Phone | 852 2369 7678 |
| Web | https://www.cms.net.cn |
China Medical Management Efficiency
The company has return on total asset
(ROA) of
0.1324 % which means that it generated a profit of $0.1324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.243 %, meaning that it generated $0.243 on every $100 dollars invested by stockholders. China Medical's management efficiency ratios could be used to measure how well China Medical manages its routine affairs as well as how well it operates its assets and liabilities.
China Medical System has accumulated 573.81
M in total debt with debt to equity ratio
(D/E) of 17.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. China Medical System has a current ratio of 5.6, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist China Medical until it has trouble settling it off, either with new capital or with free cash flow. So, China Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medical System sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medical's use of debt, we should always consider it together with cash and equity.
China Medical System Holdings Limited, an investment holding company, produces medicines and markets, promotes, and sells drugs in the Peoples Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. CHINA M operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3600 people. China Medical System (2M7C) is traded on Frankfurt Exchange in Germany and employs 5,454 people.
Management Performance
China Medical System Leadership Team
Elected by the shareholders, the China Medical's board of directors comprises two types of representatives: China Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medical's management team and ensure that shareholders' interests are well served. China Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in China Stock
China Medical financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medical security.